Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam Adjunctive Therapy in Refractory Focal Epilepsy
NCT00175929Phase 2Completed
- Sponsor
- UCB
- Start
- May 2005
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial of brivaracetam in focal epilepsy (3 arms), sponsored by UCB. Primary endpoint: Partial onset seizure frequency (Type I) per week over the 7-week maintenance period. Started May 2005; status: completed.
02
Drugs
brivaracetam
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT00175929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175929.